Pfizer is developing a direct-to-consumer platform to sell some of its drugs online, including Paxlovid, which costs $1,400 for a five-day dose, and a migraine nasal spray.

The move is the latest by Big Pharma to bypass primary care physicians and traditional pharmacies to sell drugs. It follows Eli Lilly’s launch in January of LillyDirect, which provides home delivery of diabetes, obesity and migraine medications.

Pfizer’s website will connect patients in the U.S. with independent telehealth consultants who can prescribe medications, and an online pharmacy partner will fill and ship prescriptions. The drugmaker plans to have the website up before the end of the year.


Pfizer agrees to settle over 10,000 Zantac lawsuits